Ci Investments Inc. Teva Pharmaceutical Industries LTD Transaction History

Ci Investments Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $59,620 - $103,857	-8,691 Reduced 24.5%	26,786 $216,000
Q2 2022 Aug 12, 2022	SELL	$7.38 - $10.4 $77,194 - $108,784	-10,460 Reduced 22.77%	35,477 $267,000
Q1 2022 May 12, 2022	SELL	$7.33 - $9.39 $52,915 - $67,786	-7,219 Reduced 13.58%	45,937 $431,000
Q4 2021 Feb 11, 2022	BUY	$7.9 - $10.19 $37,193 - $47,974	4,708 Added 9.72%	53,156 $426,000
Q3 2021 Nov 12, 2021	SELL	$8.38 - $10.18 $35,514 - $43,142	-4,238 Reduced 8.04%	48,448 $472,000
Q2 2021 Aug 13, 2021	BUY	$9.9 - $11.56 $105,197 - $122,836	10,626 Added 25.26%	52,686 $522,000
Q1 2021 May 13, 2021	BUY	$10.34 - $12.81 $11,797 - $14,616	1,141 Added 2.79%	42,060 $485,000
Q4 2020 Feb 09, 2021	BUY	$8.61 - $11.04 $91,756 - $117,653	10,657 Added 35.22%	40,919 $395,000
Q3 2020 Nov 09, 2020	BUY	$8.57 - $12.69 $62,895 - $93,131	7,339 Added 32.02%	30,262 $273,000
Q2 2020 Aug 07, 2020	BUY	$8.12 - $13.12 $186,134 - $300,749	22,923 New	22,923 $283,000

626

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $23.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.